FDA approved

Learn about MARQIBO
(vinCRIStine sulfate LIPOSOME injection)

What is MARQIBO?

MARQIBO is different from conventional vincristine, which is a type of
chemotherapy that is used to treat acute lymphoblastic leukemia (ALL).1
You may have already received conventional vincristine in the past.

With MARQIBO, vincristine is surrounded by a layer of lipids (fats).2 Because fats surround the vincristine, the medicine is slowly released into your system to help fight certain cancer cells (see "Who is MARQIBO for?").

MARQIBO is given through your veins as an infusion.2

The most commonly reported side effects in clinical studies were constipation, nausea, fever, nerve damage, low white cell counts with a fever, low appetite, insomnia, tiredness, diarrhea, and low red cell counts.2

For more information about MARQIBO, talk to your doctor.

 

Who is MARQIBO for?2

MARQIBO is for adults with Philadelphia chromosome–negative (Ph‒) ALL when:

  • Their leukemia has come back (relapsed) 2 or more times, or
  • Their leukemia became worse (progressed) after 2 or more anti-leukemia therapies
  • The safety and effectiveness of MARQIBO in pediatric patients have not been established
  • It is not known whether MARQIBO is excreted in human milk

To learn more about MARQIBO, click to download the Patient Information

Who is not right for MARQIBO?
  • If you have certain conditions of the brain or spinal cord, including Charcot-Marie-Tooth syndrome. Talk to your doctor before receiving MARQIBO if you have a condition that affects your brain or spinal cord
  • If you are allergic to vincristine sulfate or any of the ingredients in MARQIBO. See the end of the Important Safety Information for a list of the ingredients in MARQIBO
  • Let your doctor know if you have experienced nerve problems (neuropathy) in the past. Nerve problems are common with MARQIBO and may get worse over time. Your doctor may need to change your dose, or delay or stop your treatment with MARQIBO if you develop nerve problems

 

Resources for patients and caregivers

The following organizations offer support and information to patients and caregivers. To learn more about ALL and treatment options, visit the websites below.

Spectrum Pharmaceuticals is not responsible for the privacy policy, the content, or the accuracy of any website accessed through a link on MARQIBO.com. A link to other websites does not constitute an endorsement by Spectrum Pharmaceuticals of the linked site, its products, or services.

Remember, your doctor is your best resource. Talk to your doctor if you have any questions about MARQIBO or your symptoms.

Advocacy

LIVESTRONG Foundation
Telephone: 1-855-220-7777
www.livestrong.org

Professional Societies
American Cancer Society
Telephone: 1-800-ACS-2345
www.cancer.org

The Leukemia & Lymphoma Society
Telephone: 1-800-955-4572
www.lls.org

Other Resources
The National Cancer Institute
Telephone: 1-800-4-CANCER (226237)
www.cancer.gov

National Comprehensive Cancer Network® (NCCN®)
Telephone: 1-215-690-0300
www.nccn.org

Call your doctor for medical advice about side effects. You are encouraged to report negative side effects to the FDA. Visit www.FDA.gov/medwatch or call
1-800-FDA-1088.

Click here to download a PDF of the Prescribing Information for MARQIBO.